Quantcast

Posts related to ‘PROCRIT’

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the company itself.  Luckily for Amgen, much of the bad news ...
Read Full Story »

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday's decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels ...
Read Full Story »